Saba Labs, LLC — Form D/A

Saba Labs, LLC of BIRMINGHAM, AL, a company, filed a Form D amendment with the SEC on 2017-03-02. The offering totals $1.0M, of which $525K was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2017-03-02
Form: D/A
Accession: 0001594979-17-000001
Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $1.0M
Amount sold: $525K
Remaining: $475K
Investors: 8
Revenue range: Decline to Disclose
SEC file number: 021-257679

Issuer

Name: Saba Labs, LLC
CIK: 0001594979
Entity type: Limited Liability Company
Jurisdiction: ALABAMA
Incorporated: 2013
Address: 2501 20TH PLACE SOUTH, BIRMINGHAM, AL, 35223
Phone: 205-263-2332

Officers, directors & promoters (11)

Name	Role	Location
Hossein Dovlatabadi	Executive Officer	Hoover, AL
Madding King III	Executive Officer	Birmingham, AL
William A Legg, Jr.	Executive Officer	Birmingham, AL
Philip White	Director	Salt Lake City, UT
Philip White	Executive Officer	Salt Lake City, UT
Bob Jacobus	Executive Officer	Birmingham, AL
Madding King III	Director	Birmingham, AL
Mading King III	Director	Birmingham, AL
William A Legg, Jr.	Director	Birmingham, AL
Hossein A Dovlatabadi	Director	Hoover, AL
Hossein Dovlatabadi	Director	Hoover, AL

Other filings by this issuer (8)

Filed	Form	Offering	Sold
2017-07-28	D	$250K	$250K
2016-08-23	D/A	$850K	$850K
2016-02-18	D	$1.0M	—
2015-08-24	D/A	$1.5M	$1.2M
2015-08-24	D/A	$850K	$800K
2015-03-26	D	$750K	—
2014-03-31	D/A	$1.5M	—
2013-12-20	D	$1.5M	—

More